Blanket purchase agreement for ocaliva
Ended Awarded Last action
- Contract number
- 36E79722A0011
- Awardee
-
Intercept Pharmaceuticals Inc. UEI GHNKCLBJRMK7
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- VA797P12Q0002 Solicitation number
- Last date to order 100% complete
- IDV ceiling
- $15,000,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Department of Veterans Affairs National Acquisition Center has awarded a Blanket Purchase Agreement (BPA) to Intercept Pharmaceuticals Inc. for the supply of Ocaliva 5mg tablets. Ocaliva is an approved treatment for primary biliary cholangitis, a chronic liver disease affecting veterans. This single-award BPA, valued at up to $15,000,000 over a 3-year period of performance, was established under the Pharmaceuticals and Drugs Federal Supply Schedule. It provides an efficient procurement vehicle for the Department of Veterans Affairs to obtain Ocaliva for the treatment of primary biliary cholangitis in combination with ursodeoxycholic acid for veterans who have an inadequate response to the latter drug alone. As the sole awardee, Intercept Pharmaceuticals Inc. will deliver Ocaliva to the agency through this Indefinite Delivery Vehicle contract.
The BPA was awarded on January 25, 2022 and has an ultimate completion date of October 7, 2024. It did not involve any set-asides. The contract aims to meet the treatment needs of veterans suffering from primary biliary cholangitis by providing efficient access to Ocaliva, a critical pharmaceutical product. This contract supports the Department of Veterans Affairs' mission to care for those who have served.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Legal Contract Cancellation | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79722A0011?
36E79722A0011 was awarded to Intercept Pharmaceuticals Inc. by National Acquisition Center (Headquarters) on January 25, 2022.
How much is contract 36E79722A0011 worth?
36E79722A0011's own ceiling is $15,000,000.
Who can order from contract 36E79722A0011?
36E79722A0011 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 36E79722A0011 under another contract?
Yes. 36E79722A0011 is a blanket purchase agreement under V797D70027, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36E79722A0011 competed?
The extent of competition for 36E79722A0011 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV